Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

Virginia Arechavala-Gomeza, Sebahattin Cirak, Karen Anthony, Jennifer Morgan, Francesco Muntoni

Research output: Contribution to journalLetterResearchpeer-review

Abstract

A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.
Original languageEnglish
JournalThe Lancet
DOIs
Publication statusPublished - 14 Jan 2012

Fingerprint

Cycloaddition
Amides
Exons
Catalysts
fullerene C60

Cite this

Arechavala-Gomeza, Virginia ; Cirak, Sebahattin ; Anthony, Karen ; Morgan, Jennifer ; Muntoni, Francesco. / Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply. In: The Lancet. 2012.
@article{118f63dfa3f245578b5953466154f256,
title = "Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply",
abstract = "A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.",
author = "Virginia Arechavala-Gomeza and Sebahattin Cirak and Karen Anthony and Jennifer Morgan and Francesco Muntoni",
year = "2012",
month = "1",
day = "14",
doi = "10.1016/S0140-6736(12)60064-6",
language = "English",
journal = "The Lancet",

}

Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply. / Arechavala-Gomeza, Virginia; Cirak, Sebahattin; Anthony, Karen; Morgan, Jennifer; Muntoni, Francesco.

In: The Lancet, 14.01.2012.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

AU - Arechavala-Gomeza, Virginia

AU - Cirak, Sebahattin

AU - Anthony, Karen

AU - Morgan, Jennifer

AU - Muntoni, Francesco

PY - 2012/1/14

Y1 - 2012/1/14

N2 - A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.

AB - A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.

UR - http://www.mendeley.com/research/exonskipping-therapy-duchenne-muscular-dystrophy-authors-reply

U2 - 10.1016/S0140-6736(12)60064-6

DO - 10.1016/S0140-6736(12)60064-6

M3 - Letter

JO - The Lancet

JF - The Lancet

ER -